Skip to main content
Premium Trial:

Request an Annual Quote

MolPAGE Consortium Aims to Find Biomarkers for Diabetes, Vascular Disease

NEW YORK, April 15 (GenomeWeb News) - A European consortium of 18 academic institutions, biotechnology companies, and pharmaceutical firms has been funded by 12 million ($15.5 million) from the European Union to identify biomarkers for diabetes and vascular disease.

 

The consortium, called the Molecular Phenotyping to Accelerate Genomic Epidemiology Consortium, or MolPAGE, is led by Mark McCarthy and John Bell at OxfordUniversity

 

The diabetes research program aims to use genomic, proteomic, and metabonomic technologies to identify biomarkers that are able to highlight individuals likely to suffer from diabetes and vascular disease  before they show any of the symptoms, biochemical abnormalities, or other features typically used in the diagnosis of these conditions.

 

"Whilst the use of well-established parameters like blood glucose, cholesterol, and lipids for the diagnosis of diabetes is extremely valuable, the recent advent of gene-regulating drugs for the treatment of diabetes has highlighted the need for a deeper molecular understanding of its causes," said Bell.

 

"Using new technologies to study and characterize cohorts of patients offers the potential to identify biomarkers that predict the disease, determine risk, and relate to disease activity as well as response to therapy."

 

MolPAGE consortium members include: the University of Oxford, Oxford Genetic Technology, Centre National de Genotypage, Epigenomics, Biovision, Novo Nordisk, the Royal Institute of Technology, Affibody, Charles University, the European Bioinformatics Institute, the Institute of Mathematics & Computer Science of the University of Latvia, Imperial College of Science, Technology and Medicine; the University of Pavia, Gyros, Guys and St Thomas Hospital NHS Trust, Uppsala University, and Roche.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.